DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) share price today?

VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) is trading at ₹1,341.3 on the NSE, down 5.04% on the day. Source: DocStoX.

What is the PE ratio of VIJAYA DIAGNOSTIC CEN LTD?

VIJAYA DIAGNOSTIC CEN LTD has a price-to-earnings (PE) ratio of 79.8 in the Healthcare sector.

What is the market capitalisation of VIJAYA DIAGNOSTIC CEN LTD?

VIJAYA DIAGNOSTIC CEN LTD has a market capitalisation of approximately ₹13,777 crore.

VIJAYA DIAGNOSTIC CEN LTD

VIJAYA·NSE·Healthcare

₹1,341.30▼ -71.20 (-5.04%)

Healthcare · Healthcare Service Provider

Revenue compounding 21% a year

NIFTY 500NIFTY SMALLCAP 250

Day₹1309.50

₹1436.80

52W₹848

₹144083%

Open

₹1415.90

High

₹1436.80

Low

₹1309.50

Prev Close

₹1412.50

Volume

8.64L

VWAP

₹1337.09

Snapshot

Key fundamentals

Market Cap

₹13,777 Cr

P/E Ratio

79.79Expensive

P/B Ratio

14.85

EPS

₹16.81

Book Value

₹93.00

ROE

19.70%Strong

ROCE

21.00%Efficient

Dividend Yield

0.15%

Debt / Equity

0.44Moderate

Face Value

₹1.00

52W High

₹1440.00

52W Low

₹848.00

Sector

Healthcare

Industry

Healthcare Service Provider

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹139

▼ 89.7%downside

Trading at ₹1,341 — 90% above our estimate

BearFair valueBull

₹118₹139₹188

/100

Business quality — Solid

Growth 92Profitability 87Efficiency 33Valuation 39

Plain English

Our view

Revenue compounding 21% a year
Low debt relative to equity
Expensive — trades at 80× earnings

Strengths

Low debt relative to equity
Capital is working hard (ROCE 21%)
Revenue compounding 21% over 3 years
Profit growing 27% a year

Risks

Expensive — trades at 80× earnings
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

20% ROE fading to 13% over ~10 yrs, on ₹93 book

₹125

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹188

Analyst target

No analyst coverage

—

Blended fair value₹139

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Capital is working hard (ROCE 21%)
Revenue compounding 21% over 3 years
Profit growing 27% a year
Promoters hold a controlling stake

Bear case

Expensive — trades at 80× earnings
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

79.8Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

19.7%Strong

Above 15% is considered healthy for Indian equities

ROCE

21.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.44Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹13,777 Cr

P/B

14.85

EPS

₹16.81

Div Yield

0.15%

What changed

Recent changes

Foreign investors-1.7% stake last quarter
Domestic institutions+1.3% stake last quarter
Promoters-0.09% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 79.8×

Growth

Strong

+21% rev CAGR

Profitability

Excellent

19.7% ROE

Financial health

Comfortable

D/E 0.44

Momentum

N/A

No technicals

Today

Trading activity

Delivery %37.6%

Turnover₹11546.28L Cr

Trades55,097

VWAP₹1337.09

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+21.0%

+16.6%

10Y

—

Profit

+26.7%

+15.3%

10Y

—

EPS

+26.6%

-2.0%

10Y

—

Profile

Cons

Stock is trading at 14.9 times its book value
Working capital days have increased from -3.87 days to 65.1 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters trimmed their stake by 0.09 pts; foreign investors sold 1.72 pts; domestic institutions added 1.34 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

53%

Promoter

Promoters

52.5%-0.09

Public

3.5%+0.33

FII / FPI

13.4%-1.72

DII

29.9%+1.34

Others

0.7%

Total shareholders

62,946+5,162 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter52.51%

FII13.38%

DII29.93%

Public3.47%

Others0.71%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions